D-0519-2020 Class III Terminated
FDA drug recall D-0519-2020 was initiated by X-Gen Pharmaceuticals Inc. on Oct 11, 2019 and is designated Class III. Reason for recall: Labeling: Incorrect or Missing Package Insert - the incorrect package insert version was attached. The recall status is terminated (terminated Aug 16, 2022). Affected quantity: 25120 vials.
Recall details
- Product Type
- Drugs
- Report Date
- Nov 27, 2019
- Initiation Date
- Oct 11, 2019
- Termination Date
- Aug 16, 2022
- Voluntary/Mandated
- Voluntary: Firm initiated
- Product Quantity
- 25120 vials
Product description
Levetiracetam Injection, 500 mg/5mL, 10 single-use 5 mL vials, Rx only, Manufactured by: Agile Specialties Private Limited Pilot No. 14, Sipcot II, Hosur-635 109 Tamil Nadu, India, Manufactured for: X-Gen Pharmaceuticals, Inc. Big Flats, NY 14814, NDC 39822-4000-1
Reason for recall
Labeling: Incorrect or Missing Package Insert - the incorrect package insert version was attached.
Distribution pattern
U.S.A. Nationwide
Code information
Lot #: 7603333, 7603334, 7603335, Exp 05/2020; 7051107, Exp 01/2022
Source
- Dataset
- openFDA drug recall enforcement reports
- FDA record
- This recall in openFDA (JSON)
- Enforcement Report
- Search FDA's Enforcement Report for D-0519-2020
- openFDA file date
- Nov 10, 2026
- Loaded by RegDataLab
- Nov 11, 2026